The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Naloxone 400 microgram/ml solution for injection or infusion

Orpha-Devel Handels und Vertriebs GmbHPA1353/003/001

Main Information

Trade NameNaloxone 400 microgram/ml solution for injection or infusion
Dosage FormSolution for injection/infusion
Licence HolderOrpha-Devel Handels und Vertriebs GmbH
Licence NumberPA1353/003/001

Group Information

ATC CodeV03AB Antidotes
V03AB15 naloxone


License statusWithdrawn
Withdrawn Date01/04/2024
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back